1Kereiakes DJ,Wang H,Popma JJ,Kuntz RE,Donohoe D J,Schofer J,et al.Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents:pooled analysis of five clinical trials.J Am Coll Cardiol 2006; 48:21-31.
2Burzotta F,Siviglia M,Altamura L,Trani C,Leone AM,Romagnoli E,et al.Outcome of overlapping heterogenous drug-eluting stents and of overlapping drug-eluting and bare metal stents.Am J Cardiol 2007; 99:364-368.
3Kang WC,Oh KJ,Han SH,Ahn TH,Chang W J,Shin MS,et al.Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus-and paclitaxel-eluting stents:comparison with same drug-eluting overlapping stents.Int J Cardiol 2007; 123:12-17.
4Finn AV,Kolodgie FD,Harnek J,Guerrero L J,Acampado E,Tefera K,et al.Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus-or paclitaxel-eluting stents.Circulation 2005; 112:270-278.
5Lim SY,Jeong MH,Hong SJ,Lim do S,Moon JY,Hong YJ,et al.Inflammation and delayed endothelization with overlapping drug-eluting stents in a porcine model of in-stent restenosis.Circ J 2008; 72:463-468.
6Munoz JS,Abizaid A,Mintz GS,Albertal M,Abizaid AS,Feres F,et al.Intravascular ultrasound study of effects of overlapping sirolimus-eluting stents.Am J Cardiol 2004; 93:470-473.
7Kawaguchi R,Sabate M,Angiolillo D J,Jimenez-Quevedo P,Suzuki N,Corros C,et al.Angiographic and 3D intravascular ultrasound assessment of overlapping bare metal stent and three different formulations of drug-eluting stents in patients with diabetes mellitus.Int J Cardiovasc Imaging 2008; 24:125-132.
8Kume T,Akasaka T,Kawamoto T,Watanabe N,Toyota E,Neishi Y,et al.Assessment of coronary intima media thickness by optical coherence tomography:comparison with intravascular ultrasound.Circ J 2005; 69:903-907.
9Takano M,Inami S,Jang IK,Yamamoto M,Murakami D,Seimiya K,et al.Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation.Am J Cardiol 2007; 99:1033-1038.
10Matsumoto D,Shite J,Shinke T,Otake H,Tanino Y,Ogasawara D,et al.Neointimal coverage of sirolimus-eluting stents at 6-month follow-up:evaluated by optical coherence tomography.Eur Heart J 2007; 28:961-967.
4Kubo T,Imanishi T,Takarada S,et al.Assessment of culprit lesion morphology in acute myocardial infarction:Ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy[J].J Am Coll Cardiol,2007,50(10):933-939.
5Tanaka A,Imanishi T,Kitabata H,et al.Morphology of exertion-triggered plaque rupture in patients with acute coronary syndrome:An optical coherence tomography study[J].Circulation,2008,118(23):2368-2373.
6Matsumoto D,Shite J,Shinke T,et al.Neointimal coverage of sirolimus-eluting stents at 6-month follow-up:Evaluated by optical coherence tomography[J].Euro Heart J,2007,28(8):961-967.
7Jung IK, Tearney G, Borma B. Visuaozation of tissue prolapse between Coronary stent struts by optical coherence tomography: comparison with intravascular ultrasound. Circulation, 2001,104 (22) :2754-2758.
8Kubo T, Akasaka T. Recent advantages in intracomnary imaging techniques; focus on optical coherence tomography. Expert Rev Med Devices, 2008,5(6) :6914597.
9李占全,金元哲.冠状动脉造影与临床.2版.沈阳:辽宁科学技术出版社,2007:41.
10Kume T, Akasaka T, Kawamoto T, et al, Assessment of coronary arterial thrombus by optical coherence tomography : Am J Cardiol, 2006,97(12) :1713-1717.
